Finance

Lists
ONCO:STO
Oncopeptides AB
1,78 SEK
+1,72%
(+0,030) 1D
16 հոկ, 17:29:42 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ONCO...
Open
1,76 SEK
High
1,86 SEK
Low
1,74 SEK
Mkt. cap
676,51 մլն
Avg. vol.
7,36 մլն
Volume
5,15 մլն
52-wk high
5,79 SEK
52-wk low
1,25 SEK
EPS
-0,77 SEK
Shares outstanding
381,36 մլն
No. of employees
69
Open
1,76 SEK
High
1,86 SEK
Low
1,74 SEK
Mkt. cap
676,51 մլն
Avg. vol.
7,36 մլն
Volume
5,15 մլն
52-wk high
5,79 SEK
52-wk low
1,25 SEK
EPS
-0,77 SEK
Shares outstanding
381,36 մլն
No. of employees
69
News stories
From web sources and news partners
About Oncopeptides AB
CEO-
Employees69
Founded2000
Headquarters-
Sector-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
20,21 մլն
18,57 մլն
25,38 մլն
31,10 մլն
Cost of goods sold
288,00 հզր
1,85 մլն
320,00 հզր
966,00 հզր
Cost of revenue
288,00 հզր
1,85 մլն
320,00 հզր
966,00 հզր
Research and development expenses
17,29 մլն
35,90 մլն
21,49 մլն
23,53 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
50,91 մլն
43,19 մլն
44,27 մլն
57,56 մլն
Operating expense
66,98 մլն
79,23 մլն
62,60 մլն
78,80 մլն
Total operating expenses
67,27 մլն
81,08 մլն
62,92 մլն
79,77 մլն
Operating income
-47,05 մլն
-62,52 մլն
-37,53 մլն
-48,67 մլն
Other non operating income
-1,00 հզր
-12,33 մլն
1,00 հզր
-
EBT including unusual items
-60,76 մլն
-63,99 մլն
-32,06 մլն
-54,60 մլն
EBT excluding unusual items
-60,76 մլն
-63,28 մլն
-32,06 մլն
-54,60 մլն
Income tax expense
139,00 հզր
1,18 մլն
123,00 հզր
108,00 հզր
Effective tax rate
-0,23%
-1,85%
-0,38%
-0,20%
Other operating expenses
-1,22 մլն
139,00 հզր
-3,17 մլն
-2,29 մլն
Net income
-60,89 մլն
-65,17 մլն
-32,18 մլն
-54,71 մլն
Net profit margin
-301,25%
-351,02%
-126,79%
-175,93%
Earnings per share
-
-
-
-
Interest and investment income
-
8,55 մլն
5,47 մլն
-
Interest expense
-13,70 մլն
-
-
-5,94 մլն
Net interest expenses
-13,70 մլն
8,55 մլն
5,47 մլն
-5,94 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-46,43 մլն
-61,95 մլն
-36,96 մլն
-48,10 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps